ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TRDA Entrada Therapeutics Inc

13.25
1.40 (11.81%)
02 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)
Total Revenue 0000025.26M18.17M43.74M
Operating Income -18.46M-22.15M-23.58M-25.94M-25.58M-5.78M-16.3M14.01M
Pre Tax Income -18.45M-21.67M-23.18M-25.14M-24.63M-3.12M-12.08M18.06M
Net Income -18.45M-21.67M-23.18M-25.14M-24.63M-6.67M-25.93M35.46M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -18.46M-22.15M-23.58M-25.94M-25.58M-5.78M-16.3M14.01M
EBITDA -18.16M-21.76M-23.12M-25.42M-25.05M-5.24M-15.57M14.85M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 00129.01M
Operating Income -51.13M-97.25M-3.16M
Pre Tax Income -51.16M-94.62M12.06M
Net Income -51.16M-94.62M-6.69M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -1.638-3.014-0.2
EBIT -51.13M-97.25M-3.16M
EBITDA -50.03M-95.35M-321k

Your Recent History

Delayed Upgrade Clock